Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase.

Warnock DG, Bichet DG, Holida M, Goker-Alpan O, Nicholls K, Thomas M, Eyskens F, Shankar S, Adera M, Sitaraman S, Khanna R, Flanagan JJ, Wustman BA, Barth J, Barlow C, Valenzano KJ, Lockhart DJ, Boudes P, Johnson FK

Open source

DOI
10.1371/journal.pone.0134341
Published
2015
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0134341,
  title = {Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase.},
  author = {Warnock DG and Bichet DG and Holida M and Goker-Alpan O and Nicholls K and Thomas M and Eyskens F and Shankar S and Adera M and Sitaraman S and Khanna R and Flanagan JJ and Wustman BA and Barth J and Barlow C and Valenzano KJ and Lockhart DJ and Boudes P and Johnson FK},
  year = {2015},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0134341},
  url = {https://doi.org/10.1371/journal.pone.0134341}
}

RIS

TY  - JOUR
TI  - Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase.
AU  - Warnock DG
AU  - Bichet DG
AU  - Holida M
AU  - Goker-Alpan O
AU  - Nicholls K
AU  - Thomas M
AU  - Eyskens F
AU  - Shankar S
AU  - Adera M
AU  - Sitaraman S
AU  - Khanna R
AU  - Flanagan JJ
AU  - Wustman BA
AU  - Barth J
AU  - Barlow C
AU  - Valenzano KJ
AU  - Lockhart DJ
AU  - Boudes P
AU  - Johnson FK
PY  - 2015
JO  - PloS one
DO  - 10.1371/journal.pone.0134341
UR  - https://doi.org/10.1371/journal.pone.0134341
ER  - 

APA

DG, W., DG, B., M, H., O, G., K, N., M, T., F, E., S, S., M, A., S, S., R, K., JJ, F., BA, W., J, B., C, B., KJ, V., DJ, L., P, B., & FK, J. (2015). Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase.. PloS one. https://doi.org/10.1371/journal.pone.0134341

Source records